Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-10-10
2011-10-04
Saoud, Christine J (Department: 1647)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S326000, C435S334000, C435S252300, C435S320100, C530S387100, C530S388100, C530S388220, C536S023100
Reexamination Certificate
active
08030023
ABSTRACT:
The invention concerns anti-DR5 antibodies with improved properties, compositions comprising such antibodies, methods and means for making such antibodies, and their therapeutic use, in particular in the treatment of cancer.
REFERENCES:
patent: 4342566 (1982-08-01), Theofilopoulos et al.
patent: 4419446 (1983-12-01), Howley et al.
patent: 4485045 (1984-11-01), Regen et al.
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4560655 (1985-12-01), Baker et al.
patent: 4601978 (1986-07-01), Karin et al.
patent: 4657866 (1987-04-01), Kumar et al.
patent: 4676980 (1987-06-01), Segal et al.
patent: 4736866 (1988-04-01), Leder et al.
patent: 4767704 (1988-08-01), Cleveland et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 4927762 (1990-05-01), Darfler et al.
patent: 4975278 (1990-12-01), Senter et al.
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5047335 (1991-09-01), Paulson et al.
patent: 5122469 (1992-06-01), Mather et al.
patent: 5278299 (1994-01-01), Wong et al.
patent: 5500362 (1996-03-01), Robinson et al.
patent: 5510261 (1996-04-01), Goochee et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5739277 (1998-04-01), Presta et al.
patent: 5750373 (1998-05-01), Garrard et al.
patent: 5763223 (1998-06-01), Wiley et al.
patent: 5807715 (1998-09-01), Morrison et al.
patent: 5821333 (1998-10-01), Carter et al.
patent: 5821337 (1998-10-01), Carter et al.
patent: 6030945 (2000-02-01), Ashkenazi et al.
patent: 6072047 (2000-06-01), Rauch et al.
patent: 6113898 (2000-09-01), Anderson et al.
patent: 6252050 (2001-06-01), Ashkenazi et al.
patent: 6284236 (2001-09-01), Wiley et al.
patent: 6313269 (2001-11-01), Deen et al.
patent: 6342369 (2002-01-01), Ashkenazi et al.
patent: 6342383 (2002-01-01), Perron et al.
patent: 6433147 (2002-08-01), Ni et al.
patent: 6461823 (2002-10-01), Ni et al.
patent: 6468532 (2002-10-01), Hsei et al.
patent: 6569642 (2003-05-01), Rauch et al.
patent: 6642358 (2003-11-01), Rauch et al.
patent: 6743625 (2004-06-01), Ni et al.
patent: 6746668 (2004-06-01), Ashkenazi et al.
patent: 7115717 (2006-10-01), Mori et al.
patent: 7244429 (2007-07-01), Zhou et al.
patent: 7279160 (2007-10-01), Zhou et al.
patent: 2001/0010924 (2001-08-01), Deew et al.
patent: 2001/0023691 (2001-09-01), Sekiya
patent: 2002/0048785 (2002-04-01), Holtzman
patent: 2002/0072091 (2002-06-01), Ni et al.
patent: 2002/0098550 (2002-07-01), Ni et al.
patent: 2002/0160446 (2002-10-01), Holtzman et al.
patent: 2003/0125554 (2003-07-01), Bernard et al.
patent: 2005/0249729 (2005-11-01), Mori et al.
patent: 0003089 (1981-08-01), None
patent: 417563 (1990-08-01), None
patent: 870827 (1998-10-01), None
patent: 1 396 500 (2004-10-01), None
patent: WO 81/01145 (1981-04-01), None
patent: WO 87/00195 (1987-01-01), None
patent: WO 88/07378 (1988-10-01), None
patent: WO 90/03430 (1990-04-01), None
patent: WO 91/00360 (1991-01-01), None
patent: WO 93/06213 (1993-04-01), None
patent: WO 93/08829 (1993-05-01), None
patent: WO 94/11026 (1994-05-01), None
patent: WO 94/04690 (1994-06-01), None
patent: WO 94/29348 (1994-12-01), None
patent: WO 97/01633 (1997-01-01), None
patent: WO 97/25428 (1997-07-01), None
patent: WO 98/18921 (1998-05-01), None
patent: WO 98/25986 (1998-06-01), None
patent: WO 98/28426 (1998-07-01), None
patent: WO 98/32856 (1998-07-01), None
patent: WO 98/41629 (1998-09-01), None
patent: WO 98/46643 (1998-10-01), None
patent: WO 98/46751 (1998-10-01), None
patent: WO 98/51793 (1998-11-01), None
patent: WO 99/02653 (1999-01-01), None
patent: WO 99/09165 (1999-02-01), None
patent: WO 99/11791 (1999-03-01), None
patent: WO 99/36535 (1999-07-01), None
patent: WO 99/37684 (1999-07-01), None
patent: WO 99/64461 (1999-12-01), None
patent: WO 00/73349 (2000-12-01), None
patent: WO 00/75191 (2000-12-01), None
patent: WO 01/00832 (2001-01-01), None
patent: WO 02/09755 (2002-02-01), None
patent: WO 02/097033 (2002-12-01), None
patent: WO 03/037913 (2003-05-01), None
patent: WO 03/042367 (2003-05-01), None
patent: WO 03/066661 (2003-08-01), None
patent: WO 2005/100399 (2005-10-01), None
patent: WO 2007/027713 (2007-03-01), None
patent: WO 2007/128231 (2007-11-01), None
patent: WO 2008/066854 (2008-06-01), None
Wells, J.A. (1990). Additivity of mutational effects in proteins. Biochemistry. 29(37):8509-8517.
Ngo et al. (1994). Computational complexity, protein structure prediction, and the Levinthal paradox. In Merz and Le Grand (Eds.) The Protein Folding Problem and Tertiary Structure Prediction. Birkhauser:Boston, pp. 491-495.
Skolnick et al. (2000). From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotechnology. 18:34-39.
Wang et al. (1999). Rapid analysis of gene expression (RAGE) facilitates universal expression profiling. Nucleic Acds Research. 27(23):4609-4618.
Kaufman et al. (1999). Transgenic analysis of a 100-kb human B-globulin cluster-containing DNA fragment propagated as a bacterial artificial chromosome. Blood. 94(9):3178-3184.
Rudikoff et al. (1982). Single amino acid substitution altering antigen-binding specificity. Proc. Natl. Acad. Sci. USA. 79:1979-1983.
AgnewChem Intl. Ed. Engl. 33:183-186 (1994).
Anderson et al.,Nature, 390:175-179 (1997).
Armitage et al. Nature, 357:80-82 (1992).
Ashkenazi and Dixit,Curr. Opin. Cell Biol., 11:255-260 (2000.
Ashkenazi and Dixit,Science, 281:1305-1308 (1998).
Ashkenazi et al., J. Clin. Invest., 104:155-162 (1999).
Ashkenazi,Nature Reviews, 2:420-430 (2002).
Bodmer et al.,Nature Cell Biol., 2:241-243 (2000).
Boerner et al.,J. Immunol., 147 (1):86-95 (1991.
Boyd et al.,Mol. Immunol. 32:1311-1318 [1996].
Bradley, inTeratocarcinomas and Embryonic Stem Cells: A Practical Approach, E. J. Robertson, ed. (IRL, Oxford, 1987), pp. 113-152.
Brennan et al.,Science229:81 (1985).
Brodeur et al.,Monoclonal Antibody Production Techniques and Applications, Marcel Dekker, Inc., New York, (1987) pp. 51-63.
Browning et al., Cell, 72:847-856 (1993).
Buchsbaum Donald J, et al., “Antitumor efficacy of TRA-8 Anti-DR5 Monoclonal Antibody alone or in combination with Chemotherapy and/or Radiation Therapy in a Human Breast Cancer Model”, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, Sep. 1, 2003, pp. 3731-3741.
Burton,Molec. Immunol. 22:161-206 (1985).
Capel et al.,Immunomethods, 4:25-34 (1994).
Carter et al.,Bio/Technology10:163-167 (1992).
Cha et al., Immunity, 11:253-261 (1999).
Chicheportiche et al.,J. Biol. Chem., 272:32401-32410 (1997.
Chothia et al.,J. Mol. Biol., 186:651-663 (1985).
Clackson et al.,Nature 352, 624-628 (1991).
Clynes et al.PNAS(USA), 95:652-656 (1998).
Cole et al.,Monoclonal Antibodies and Cancer Therapy, Alan R. Liss, p. 77 (1985).
Cunningham and WellsScience, 244:1081-1085 (1989).
Daëron,Annu. Rev. Immunol., 15:203-234 (1997).
David et al.,Biochemistry, 13:1014-1021 (1974).
Dealtry et al., Eur. J. Immunol., 17:689 (1987).
Degli-Esposti et al.,Immunity, 7:813-820 (1997).
FcRs are reviewed in Ravetch and Kinet,Annu. Rev. Immunol., 9:457-92 (1991).
Fishwild et al.,Nature Biotechnology, 14: 845-51 (1996.
Gazitt, Leukemia, 13:1817-1824 (1999.
Gazzano-Santoro et al.,J. Immunol. Methods, 202:163 (1996).
Goding,Monoclonal Antibodies: Principles and Practice, Academic Press, (1986) pp. 59-103.
Gorman et al., DNA Prot. Eng Tech 2: 3-10, 1990.
Graham et al.,J. Gen. Virol., 36:59-74, (1977).
Griffith et al., J. Exp. Med., 189:1343-1353 (1999).
Griffith T.S., et al., “Functional Analysis of Trail Receptors Using Monoclonal Antibodies”, Journal of Immunology, vol. 162, Mar. 1, 1999, pp. 2597-2605.
Guss et al.,EMBO J. 5:1567-1575 (1986).
Guyer et al.,J. Immunol., 117:587 (1976).
Haas et al, J. Lab. Clin. Med., 126: 330-341, 1995.
Handbook of Monoclonal Antibodies, Ferrone et al., eds., Noges Publications, Park Ridge, N.J., (1985) c
Adams Camellia W.
Ashkenazi Avi J.
Arnold & Porter LLP
Dreger Ginger R.
Genentech Inc.
Lockard Jon M
Marschang Diane
LandOfFree
Nucleic acid encoding DR5 antibodies and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid encoding DR5 antibodies and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid encoding DR5 antibodies and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4287565